Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023

BUY
$14.1 - $19.83 $317,926 - $447,126
22,548 New
22,548 $362,000
Q4 2022

Feb 13, 2023

BUY
$6.45 - $12.07 $369,372 - $691,212
57,267 Added 383.57%
72,197 $667,000
Q3 2022

Nov 07, 2022

SELL
$7.86 - $12.91 $89,525 - $147,044
-11,390 Reduced 43.28%
14,930 $128,000
Q2 2022

Aug 09, 2022

SELL
$7.06 - $13.97 $219,078 - $433,503
-31,031 Reduced 54.11%
26,320 $214,000
Q1 2022

May 16, 2022

BUY
$12.15 - $35.28 $696,814 - $2.02 Million
57,351 New
57,351 $696,000
Q3 2021

Nov 09, 2021

SELL
$41.66 - $52.52 $211,799 - $267,011
-5,084 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$36.62 - $51.69 $186,176 - $262,791
5,084 New
5,084 $229,000
Q4 2020

Feb 12, 2021

SELL
$36.08 - $56.47 $106,977 - $167,433
-2,965 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$33.26 - $40.48 $98,615 - $120,023
2,965 New
2,965 $109,000
Q2 2020

Aug 13, 2020

SELL
$24.21 - $31.02 $62,364 - $79,907
-2,576 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$20.5 - $34.53 $52,808 - $88,949
2,576 New
2,576 $71,000
Q4 2019

Feb 10, 2020

SELL
$18.96 - $29.84 $146,086 - $229,917
-7,705 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$19.12 - $26.24 $311,005 - $426,819
-16,266 Reduced 67.86%
7,705 $147,000
Q2 2019

Aug 13, 2019

BUY
$19.57 - $24.1 $469,112 - $577,701
23,971 New
23,971 $525,000
Q1 2019

May 13, 2019

SELL
$12.14 - $20.46 $750,871 - $1.27 Million
-61,851 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$11.24 - $18.5 $695,205 - $1.14 Million
61,851 New
61,851 $779,000
Q3 2018

Nov 13, 2018

SELL
$12.5 - $15.38 $3,750 - $4,614
-300 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$7.99 - $14.05 $2,397 - $4,215
300 New
300 $3,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.13B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.